Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-MSH) and atrial natriuretic protein (ANP) and uses in hypertension and acute kidney injury

Details for Australian Patent Application No. 2008274845 (hide)

Owner Theratechnologies Inc.

Inventors Habi, Abdelkrim; Peri, Krishna

Agent Cullens

Pub. Number AU-A-2008274845

PCT Pub. Number WO2009/006732

Priority 60/948,292 06.07.07 US

Filing date 4 July 2008

Wipo publication date 15 January 2009

International Classifications

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C07K 14/58 (2006.01) Peptides having more than 20 amino acids

C07K 14/685 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/006732 Priority application(s): WO2009/006732

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008274851-Collapsible plastic container

2008274842-Medication dose administration and inventory management